Hantz Financial Services, Inc. Medicinova Inc Transaction History

Hantz Financial Services, Inc.

  • $5.74 Billion
  • Q4 2024

A detailed history of Hantz Financial Services, Inc. transactions in Medicinova Inc stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 4,300 shares of MNOV stock, worth $7,052. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,300
Previous 4,300 -0.0%
Holding current value
$7,052
Previous $9,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$1.13 - $2.1 $2,824 - $5,250
2,500 Added 138.89%
4,300 $9,000
Q2 2024

Jul 30, 2024
BUY
$1.28 - $1.57 $2,304 - $2,826
1,800 New
1,800 $3,000

Others Institutions Holding MNOV

# of Institutions
29
Shares Held
5.13M
Call Options Held
0
Put Options Held
0
View Full List

About MEDICINOVA INC

MNOV Quotes by TradingView
  • Ticker MNOV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,046,200
  • Market Cap $80.4M
  • Description
  • MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...
More about MNOV
Track This Portfolio

Track Hantz Financial Services, Inc. Portfolio

Follow Hantz Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email